- Recon: BMS to construct AI supercomputer with Nividia; Tempus to acquire cancer diagnostic maker Personalis for $1.5B<p>Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.</p>raps · 5d ago↗ source
- Asia-Pacific Roundup: TGA seeks feedback on Australian regulations for digital mental health tools<p>Australia’s Therapeutic Goods Administration (TGA) is holding a consultation to inform changes to the regulatory framework for digital mental health tools (DMHTs).</p>raps · 5d ago↗ source
- Study: China outpaces the US in cancer approvals, lags behind on first approvals<p>While China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more…